DT
RCUS icon

Diversified Trust’s Arcus Biosciences RCUS Stock Holding History

Diversified Trust’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,545
Closed -$206K – 957
2024
Q2 		$206K Buy
13,545
+1,467
+12% +$23.7K 0.01% 781
2024
Q1 		$228K Buy
+12,078
New +$209K 0.01% 720
2022
Q4 		– Sell
-8,645
Closed -$226K – 844
2022
Q3 		$226K Sell
8,645
-382
-4% -$10.1K 0.01% 658
2022
Q2 		$229K Hold
9,027
– – 0.01% 649
2022
Q1 		$285K Hold
9,027
– – 0.01% 641
2021
Q4 		$365K Buy
9,027
+599
+7% +$23.2K 0.01% 563
2021
Q3 		$294K Hold
8,428
– – 0.01% 603
2021
Q2 		$231K Hold
8,428
– – 0.01% 656
2021
Q1 		$237K Buy
+8,428
New +$293K 0.01% 632

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Diversified Trust's RCUS Position: Q3 2024 in Review

Diversified Trust sold out of Arcus Biosciences (RCUS) in Q3 2024, closing a stake of 13,545 shares — an estimated $206K sold.

Diversified Trust first reported a position in RCUS in Q1 2021 and held it in 9 quarters. The position peaked at $365K in Q4 2021. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

  • Diversified Trust reported no remaining Arcus Biosciences position as of Q3 2024 after selling out during the quarter.
  • Diversified Trust sold 13,545 Arcus Biosciences shares in Q3 2024, an estimated $206K.
  • Diversified Trust first reported a position in Arcus Biosciences in Q1 2021 and held it in 9 quarters.
  • Diversified Trust's Arcus Biosciences position peaked at $365K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on Diversified Trust's 13F filing for Q3 2024, filed 7 Oct 2024.